AdaptHealth Director Ups Stake to 77,346 Shares, Form 4 Shows

Rhea-AI Filing Summary

AdaptHealth Corp. (AHCO) filed a Form 4 reporting that director Bradley J. Coppens acquired 21,346 shares of common stock on 06/26/2025. The shares were recorded at a stated price of $0.00, indicating a grant or other non-cash issuance. Following the transaction, Coppens’ direct ownership stands at 77,346 AHCO shares. No derivative securities were reported, and no other officers or insiders were listed on this filing.

Positive

• Insider acquisition: Director Bradley Coppens received 21,346 shares, lifting his direct stake to 77,346 shares, modestly aligning insider and shareholder interests.

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, non-cash insider share grant; marginally positive signal, immaterial to overall float.

The filing shows a routine equity grant to Director Bradley Coppens, increasing his stake to 77,346 shares. While insider accumulation is generally viewed favorably, the 21,346-share addition is minor relative to AdaptHealth’s total shares outstanding and therefore unlikely to move the stock. No derivatives, sales, or 10b5-1 plan usage were disclosed, limiting interpretive complexity. Overall impact is neutral from a valuation perspective but incrementally positive for governance alignment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coppens Bradley J

(Last) (First) (Middle)

C/O ONE EQUITY PARTNERS

510 MADISON AVENUE, 19TH FLOOR

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2025		A		21,346	A	$0	77,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Richard Rew, as attorney-in-fact for Bradley J. Coppens	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AdaptHealth (AHCO) shares did Director Bradley J. Coppens acquire?

He acquired 21,346 shares of common stock.

What is Coppens’ total direct ownership in AHCO after the transaction?

His direct holdings increased to 77,346 shares.

What price was reported for the acquired shares?

The Form 4 lists a price of $0.00, indicating a non-cash grant.

Does the Form 4 include any derivative security transactions?

No, the filing reports no derivative securities acquired or disposed of.

When was the Form 4 for AdaptHealth (AHCO) filed?

The form was signed and filed on 06/30/2025.